These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 7949653
1. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression. King MJ, Chan A, Roe R, Warren BF, Dell A, Morris HR, Bartolo DC, Durdey P, Corfield AP. Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653 [Abstract] [Full Text] [Related]
3. O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome. Blumenfeld OO, Lalezari P, Khorshidi M, Puglia K, Fukuda M. Blood; 1992 Nov 01; 80(9):2388-95. PubMed ID: 1421410 [Abstract] [Full Text] [Related]
6. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression. Brockhausen I, Yang J, Lehotay M, Ogata S, Itzkowitz S. Biol Chem; 2001 Feb 01; 382(2):219-32. PubMed ID: 11308020 [Abstract] [Full Text] [Related]
8. Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma. Zhuang D, Yousefi S, Dennis JW. Cancer Biochem Biophys; 1991 Nov 01; 12(3):185-98. PubMed ID: 1844911 [Abstract] [Full Text] [Related]
9. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies. Hiraiwa N, Tsuyuoka K, Li YT, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R. Cancer Res; 1990 Sep 01; 50(17):5497-503. PubMed ID: 2167157 [Abstract] [Full Text] [Related]
13. Coexpression of sialosyl-Tn (NeuAc alpha 2----6GalNAc alpha 1----O-Ser/Thr) and Tn (GalNAc alpha 1----O-Ser/Thr) blood group antigens on Tn erythrocytes. Kjeldsen T, Hakomori S, Springer GF, Desai P, Harris T, Clausen H. Vox Sang; 1989 Sep 01; 57(1):81-7. PubMed ID: 2800471 [Abstract] [Full Text] [Related]
14. Alterations of O-glycan biosynthesis in human colon cancer tissues. Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I. Glycobiology; 1994 Dec 01; 4(6):873-84. PubMed ID: 7734850 [Abstract] [Full Text] [Related]
15. Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase. Kono M, Tsuda T, Ogata S, Takashima S, Liu H, Hamamoto T, Itzkowitz SH, Nishimura S, Tsuji S. Biochem Biophys Res Commun; 2000 May 27; 272(1):94-7. PubMed ID: 10872809 [Abstract] [Full Text] [Related]
17. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I. Eur J Biochem; 1994 Jun 01; 222(2):415-24. PubMed ID: 8020479 [Abstract] [Full Text] [Related]
18. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom. Springer GF, Desai PR. Mol Immunol; 1985 Nov 01; 22(11):1303-10. PubMed ID: 2417112 [Abstract] [Full Text] [Related]
19. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Orntoft TF, Harving N, Langkilde NC. Int J Cancer; 1990 Apr 15; 45(4):666-72. PubMed ID: 2323843 [Abstract] [Full Text] [Related]
20. Polyvalent GalNAcalpha1-->Ser/Thr (Tn) and Galbeta1-->3GalNAcalpha1-->Ser/Thr (T alpha) as the most potent recognition factors involved in Maclura pomifera agglutinin-glycan interactions. Wu AM. J Biomed Sci; 2005 Apr 15; 12(1):135-52. PubMed ID: 15864746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]